J J Haitsma1, B Lachmann, P J Papadakos. 1. Departments of Anesthesiology, Surgery and Neurosurgery, University of Rochester, School of Medicine and Dentistry, Rochester, NY, USA.
Abstract
BACKGROUND: It has been suggested that propofol with ethylenediaminetetraacetic acid (EDTA) can modulate the systemic inflammatory response. Prolonged higher levels of pulmonary inflammation are associated with poor outcome of patients with acute lung injury. In the present study, we hypothesized that pulmonary inflammation could be modulated by propofol with EDTA compared with propofol with sulfite. METHODS: Respiratory distress was induced in rats (n=25) by intratracheal nebulization of lipopolysaccharide (LPS). After 24 h, animals were randomized to either propofol with EDTA (Propofol(EDTA)), propofol with sulfite (Propofol(sulfite)) or ketamine/midazolam (Ket/Mid); control animals received saline (n=30). Animals were ventilated for 4 h and blood gases were measured hourly. Bronchoalveolar lavage (BAL) was performed for cytokine analysis of: tumor necrosis factor (TNF), interleukin (IL)-6 and macrophage inflammatory protein (MIP)-2. RESULTS: LPS led to increased pulmonary inflammation in all groups compared with the control groups. Gas exchange deteriorated over time only in the LPS Propofol(sulfite) group and was significantly lower than the Ket/Mid group. Only IL-6 was significantly higher in the LPS Propofol(sulfite) group compared with both the Ket/Mid group and the Propofol(EDTA) group. CONCLUSION: Pulmonary IL-6 can be modulated by additives in systemic anesthesia. IMPLICATION STATEMENT: This study demonstrates that pulmonary inflammation caused by direct lung injury can be modulated by intravenous anesthesia used in critically ill patients.
BACKGROUND: It has been suggested that propofol with ethylenediaminetetraacetic acid (EDTA) can modulate the systemic inflammatory response. Prolonged higher levels of pulmonary inflammation are associated with poor outcome of patients with acute lung injury. In the present study, we hypothesized that pulmonary inflammation could be modulated by propofol with EDTA compared with propofol with sulfite. METHODS: Respiratory distress was induced in rats (n=25) by intratracheal nebulization of lipopolysaccharide (LPS). After 24 h, animals were randomized to either propofol with EDTA (Propofol(EDTA)), propofol with sulfite (Propofol(sulfite)) or ketamine/midazolam (Ket/Mid); control animals received saline (n=30). Animals were ventilated for 4 h and blood gases were measured hourly. Bronchoalveolar lavage (BAL) was performed for cytokine analysis of: tumor necrosis factor (TNF), interleukin (IL)-6 and macrophage inflammatory protein (MIP)-2. RESULTS:LPS led to increased pulmonary inflammation in all groups compared with the control groups. Gas exchange deteriorated over time only in the LPSPropofol(sulfite) group and was significantly lower than the Ket/Mid group. Only IL-6 was significantly higher in the LPSPropofol(sulfite) group compared with both the Ket/Mid group and the Propofol(EDTA) group. CONCLUSION: Pulmonary IL-6 can be modulated by additives in systemic anesthesia. IMPLICATION STATEMENT: This study demonstrates that pulmonary inflammation caused by direct lung injury can be modulated by intravenous anesthesia used in critically illpatients.
Authors: Michael A Smith; Maho Hibino; Bonnie A Falcione; Katherine M Eichinger; Ravi Patel; Kerry M Empey Journal: Ann Pharmacother Date: 2013-11-04 Impact factor: 3.154
Authors: Jan Florian Heuer; Paolo Pelosi; Peter Hermann; Christina Perske; Thomas A Crozier; Wolfgang Brück; Michael Quintel Journal: Intensive Care Med Date: 2011-05-05 Impact factor: 17.440
Authors: John M Bonvini; Beatrice Beck-Schimmer; Sonja J Kuhn; Sereina M Graber; Thomas A Neff; Martin Schläpfer Journal: PLoS One Date: 2015-07-21 Impact factor: 3.240
Authors: Christian Fastner; Heimo Mairbäurl; Nina C Weber; Koen van der Sluijs; Florian Hackl; Lorenz Hotz; Albert Dahan; Markus W Hollmann; Marc M Berger Journal: PLoS One Date: 2014-11-11 Impact factor: 3.240
Authors: Martin Schläpfer; Tobias Piegeler; Randal O Dull; David E Schwartz; Mao Mao; Marcelo G Bonini; Birgit Roth Z'Graggen; Beatrice Beck-Schimmer; Richard D Minshall Journal: Crit Care Date: 2015-02-19 Impact factor: 9.097